Capital Markets

India’s market regulator, the Securities and Exchange Board of India (SEBI), has confirmed enforcement action against pharmaceutical company Par Drugs and Chemicals Ltd following findings related to regulatory non-compliance. The decision reflects SEBI’s ongoing efforts to strengthen transparency and accountability in India’s capital markets. According to officials, the order addresses alleged irregularities concerning disclosure norms and corporate governance obligations.

Packaging manufacturer Bharat PET has taken a significant step toward entering India’s capital markets by filing draft papers with the Securities and Exchange Board of India for an initial public offering (IPO) valued at approximately Rs.760 crore. The proposed listing reflects growing investor interest in India’s industrial and packaging sectors, driven by expanding consumer markets and supply-chain modernization. According to regulatory filings, the company intends to use the capital raised to support business expansion, debt reduction, and operational upgrades.